Aspira Womens Health Stock Net Asset
| AWH Stock | USD 0.75 0.02 2.74% |
Aspira Womens Health fundamentals help investors to digest information that contributes to Aspira Womens' financial success or failures. It also enables traders to predict the movement of Aspira Stock. The fundamental analysis module provides a way to measure Aspira Womens' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aspira Womens stock.
Aspira | Net Asset |
Aspira Womens Health Company Net Asset Analysis
Aspira Womens' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Aspira Womens Net Asset | 6.26 M |
Most of Aspira Womens' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspira Womens Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aspira Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Aspira Womens is extremely important. It helps to project a fair market value of Aspira Stock properly, considering its historical fundamentals such as Net Asset. Since Aspira Womens' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aspira Womens' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aspira Womens' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Aspira Total Assets
Total Assets |
|
Based on the recorded statements, Aspira Womens Health has a Net Asset of 6.26 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Aspira Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aspira Womens' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aspira Womens could also be used in its relative valuation, which is a method of valuing Aspira Womens by comparing valuation metrics of similar companies.Aspira Womens is currently under evaluation in net asset category among its peers.
Aspira Womens Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aspira Womens from analyzing Aspira Womens' financial statements. These drivers represent accounts that assess Aspira Womens' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aspira Womens' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 21.0M | 70.1M | 675.9M | 37.7M | 33.9M | 32.2M | |
| Enterprise Value | 13.1M | 59.7M | 664.3M | 37.9M | 34.1M | 32.4M |
Aspira Womens Institutional Holders
Institutional Holdings refers to the ownership stake in Aspira Womens that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aspira Womens' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aspira Womens' value.| Shares | M&t Bank Corp | 2024-06-30 | 15 K | Two Sigma Securities, Llc | 2024-06-30 | 13.5 K | Squarepoint Ops Llc | 2024-06-30 | 12.3 K | Hrt Financial Llc | 2024-06-30 | 10.9 K | Tower Research Capital Llc | 2024-06-30 | 6.7 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 4.8 K | Royal Bank Of Canada | 2024-06-30 | 2.3 K | Advisor Group Holdings, Inc. | 2024-06-30 | 2.3 K | Jpmorgan Chase & Co | 2024-06-30 | 2.1 K | Armistice Capital, Llc | 2024-09-30 | 1.3 M | Vanguard Group Inc | 2024-09-30 | 274.1 K |
Aspira Fundamentals
| Return On Equity | -7.23 | ||||
| Return On Asset | -1.86 | ||||
| Profit Margin | (1.79) % | ||||
| Operating Margin | (1.81) % | ||||
| Current Valuation | 12.05 M | ||||
| Shares Outstanding | 16.06 M | ||||
| Shares Owned By Insiders | 30.94 % | ||||
| Shares Owned By Institutions | 13.89 % | ||||
| Number Of Shares Shorted | 537.64 K | ||||
| Price To Earning | 16.82 X | ||||
| Price To Book | 5.02 X | ||||
| Price To Sales | 1.35 X | ||||
| Revenue | 9.15 M | ||||
| Gross Profit | 4.32 M | ||||
| EBITDA | (16.49 M) | ||||
| Net Income | (16.69 M) | ||||
| Cash And Equivalents | 20.48 M | ||||
| Cash Per Share | 0.18 X | ||||
| Total Debt | 2.85 M | ||||
| Debt To Equity | 0.24 % | ||||
| Current Ratio | 3.26 X | ||||
| Book Value Per Share | (0.22) X | ||||
| Cash Flow From Operations | (15.89 M) | ||||
| Short Ratio | 4.15 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Target Price | 4.25 | ||||
| Number Of Employees | 64 | ||||
| Beta | 1.44 | ||||
| Market Capitalization | 12.05 M | ||||
| Total Asset | 6.26 M | ||||
| Retained Earnings | (518.3 M) | ||||
| Working Capital | 10.53 M | ||||
| Current Asset | 13.53 M | ||||
| Current Liabilities | 4.13 M | ||||
| Five Year Return | 2.10 % | ||||
| Net Asset | 6.26 M |
About Aspira Womens Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aspira Womens Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aspira Womens using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aspira Womens Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:Check out Aspira Womens Piotroski F Score and Aspira Womens Altman Z Score analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.801 | Quarterly Revenue Growth (0.03) | Return On Assets (1.86) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.